Poristal Tablet (Trimebutine Maleate)

Adult dose

Administer 100-200 mg of Trimebutine Maleate orally three times a day before meals. Adjust dosage as appropriate according to age and symptoms.

This medication may affect the gastrointestinal tract and can rarely cause constipation, diarrhea, borborygmi (stomach noises), nausea, vomiting, dyspepsia, dry mouth, or a sensation of numbness in the mouth. Additionally, symptoms of rapid heartbeat can rarely occur, so caution is necessary. Mentally, symptoms such as fatigue, drowsiness, dizziness, lethargy, and headaches can rarely arise. Since it may affect liver function, there is a possibility of elevated liver enzyme levels, so liver health should be monitored. Allergic reactions can manifest as a skin rash, and if such symptoms appear, medication should be stopped immediately. As the safety of this medication during pregnancy has not been fully confirmed, women who are pregnant or may become pregnant should use this medication only if the benefits outweigh the risks. Breastfeeding women should ideally avoid this medication, and if it must be taken, it is advisable to discontinue breastfeeding.

Mild side effects

• Constipation
• diarrhea
• abdominal distension
• nausea
• vomiting
• dyspeptic symptoms
• dry mouth
• oral numbness
• palpitations
• fatigue

This medication should be stored in a tightly closed container to prevent air or moisture exposure, and it is best to store it at room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance

White round tablets

Package unit

For domestic use - 10 tablets/PTP [(10 tablets/PTPX1)], for export - 100 PTP/box [(10 tablets x 10 blisters)]